"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
Descriptor ID |
D000284
|
MeSH Number(s) |
E02.319.267.100
|
Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 4 | 4 |
1995 | 0 | 13 | 13 |
1996 | 0 | 10 | 10 |
1997 | 0 | 16 | 16 |
1998 | 0 | 15 | 15 |
1999 | 0 | 15 | 15 |
2000 | 0 | 8 | 8 |
2001 | 0 | 19 | 19 |
2002 | 0 | 23 | 23 |
2003 | 0 | 19 | 19 |
2004 | 0 | 15 | 15 |
2005 | 0 | 20 | 20 |
2006 | 0 | 14 | 14 |
2007 | 0 | 19 | 19 |
2008 | 0 | 15 | 15 |
2009 | 0 | 17 | 17 |
2010 | 0 | 14 | 14 |
2011 | 0 | 17 | 17 |
2012 | 0 | 11 | 11 |
2013 | 0 | 20 | 20 |
2014 | 0 | 15 | 15 |
2015 | 0 | 18 | 18 |
2016 | 0 | 23 | 23 |
2017 | 0 | 18 | 18 |
2018 | 0 | 21 | 21 |
2019 | 0 | 17 | 17 |
2020 | 0 | 19 | 19 |
2021 | 0 | 11 | 11 |
2022 | 0 | 7 | 7 |
2023 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Fabrication of solid lipid nanoparticles-based patches of paroxetine and their ex-vivo permeation behaviour. Artif Cells Nanomed Biotechnol. 2023 Dec; 51(1):108-119.
-
Reader Response: Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant. Neurology. 2023 Nov 28; 101(22):1032-1033.
-
Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ. Nature. 2023 Aug; 620(7973):386-392.
-
Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets. AAPS J. 2023 04 21; 25(3):45.
-
Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method. Am Heart J. 2023 06; 260:124-140.
-
Oral administration of the commensal Alistipes onderdonkii prolongs allograft survival. Am J Transplant. 2023 02; 23(2):272-277.
-
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials. Ann Allergy Asthma Immunol. 2022 Dec; 129(6):758-768.e4.
-
Profound effects of gastric secretion rate variations on the precipitation of erlotinib in duodenum - An in vitro investigation. Int J Pharm. 2022 May 10; 619:121722.
-
Immune mediated oral diseases. Dis Mon. 2023 01; 69(1):101347.
-
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022 03; 53(3):728-738.